08/13/2024 3:42 PM | aTYR PHARMA INC (Filer) Atyr PHARMA (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/24/2024 4:29 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 7:30 AM | aTYR PHARMA INC (Filer) Atyr PHARMA (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 7:26 AM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) DENYES NANCY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:34 AM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:38 AM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:27 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Gross Jane A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/23/2024 6:30 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) CLARKE JOHN K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:07 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) COUGHLIN TIMOTHY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:11 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Zaknoen Sara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:16 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:19 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Lucas Svetlana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:38 PM | aTYR PHARMA INC (Filer) Atyr PHARMA (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 12:43 PM | aTYR PHARMA INC (Subject) Atyr PHARMA (Subject) LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
02/09/2024 7:35 AM | aTYR PHARMA INC (Subject) Atyr PHARMA (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024 7:20 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:15 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) DENYES NANCY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:18 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 9:17 AM | aTYR PHARMA INC (Subject) Atyr PHARMA (Subject) FEDERATED HERMES, INC. (Filed by) FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A | |
01/09/2024 6:35 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:30 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) DENYES NANCY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:33 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 11:21 AM | aTYR PHARMA INC (Subject) Atyr PHARMA (Subject) Logos Global Management LP (Filed by)
| Form SC 13G | |
12/12/2023 5:50 PM | aTYR PHARMA INC (Issuer) Atyr PHARMA (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 11:15 PM | aTYR PHARMA INC (Filer) Atyr PHARMA (Filer)
| Form EFFECT | |
09/26/2023 8:01 AM | aTYR PHARMA INC (Filer) Atyr PHARMA (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 7:04 AM | aTYR PHARMA INC (Filer) Atyr PHARMA (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |